{"id":3070,"date":"2021-05-07T00:23:49","date_gmt":"2021-05-07T00:23:49","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=3070"},"modified":"2023-08-29T17:49:24","modified_gmt":"2023-08-29T17:49:24","slug":"invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=3070","title":{"rendered":"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf"},"content":{"rendered":"<p>\u751f\u7269\u5236\u836f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IXC&amp;lang=cn\">Invex Therapeutics (ASX: IXC)<\/a>\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002<\/p>\n<p>Invex\u4e13\u6ce8\u4e8e\u5c06Presendin\u5546\u4e1a\u5316\uff0c\u7528\u4e8e\u6cbb\u7597\u9885\u5185\u538b\u5347\u9ad8\u5f15\u8d77\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u3002<\/p>\n<p>\u4eca\u5929\u7684\u65b0\u95fb\u662f\u5728\u65b0\u51a0\u80ba\u708e\u76f8\u5173\u6311\u6218\u548c\u5ef6\u8bef\u7684\u60c5\u51b5\u4e0b\u53d1\u5e03\u7684\u3002<\/p>\n<p>Invex\u8bc4\u4f30\u4e86\u4e00\u4e9b\u4e13\u95e8\u7528\u4e8e\u4e34\u5e8a\u548c\u5546\u4e1a\u76ee\u7684\u7684\u80bd\u7684\u5408\u6210\u7684CMOs\u3002<\/p>\n<p>\u4f5c\u4e3a\u8be5\u8fc7\u7a0b\u7684\u4e00\u90e8\u5206\uff0c\u8be5\u516c\u53f8\u6536\u5230\u4e86\u51e0\u4efd\u751f\u4ea7Presendin\u7684\u8be6\u7ec6\u63d0\u6848\uff0c\u7528\u4e8e\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\u548c\u5546\u4e1a\u4f9b\u5e94\u3002<\/p>\n<p>\u8fd9\u4e9b\u5efa\u8bae\u7b26\u5408\u73b0\u884c\u4e25\u683c\u7684\u826f\u597d\u751f\u4ea7\u89c4\u8303\u76d1\u7ba1\u8981\u6c42\uff0c\u5305\u62ec\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u548c\u6b27\u6d32\u836f\u7269\u7ba1\u7406\u5c40\u6240\u89c4\u5b9a\u7684\u8981\u6c42\u3002<\/p>\n<p>Invex\u968f\u540e\u5bf9\u5546\u4e1a\u4ea7\u91cf\u4e0b\u7684\u5355\u4f4d\u6210\u672c\u8fdb\u884c\u4e86\u989d\u5916\u5206\u6790\u3002\u8be5\u5206\u6790\u5305\u62ec\u6f5c\u5728\u7684\u5b9a\u4ef7\u7ed3\u6784\uff0c\u5e76\u8003\u8651\u5230\u5e02\u573a\u51c6\u5165\u52a8\u6001\u548c\u603b\u4f53\u60a3\u8005\u53ef\u63a5\u53d7\u6027\u3002<\/p>\n<p>Invex\u8868\u793a:\u201c\u6709\u5173\u63d0\u8bae\u548c\u5408\u540c\u7684\u8ba8\u8bba\u5df2\u7ecf\u975e\u5e38\u6df1\u5165\uff0c\u6b63\u5728\u8fdb\u884c\u8fdb\u4e00\u6b65\u7684\u6cd5\u5f8b\u548c\u5546\u4e1a\u5ba1\u67e5\u3002\u201d<\/p>\n<p>\u201c\u4e00\u65e6\u5236\u9020\u9009\u62e9\u8fc7\u7a0b\u5b8c\u6210\uff0c\u5e76\u7b7e\u7f72\u6709\u7ea6\u675f\u529b\u7684\u5236\u9020\u534f\u8bae\uff0cInvex\u5c06\u66f4\u65b0\u5e02\u573a\u3002\u201d<\/p>\n<p>\u622a\u81f33\u6708\u5e95\uff0cInvex\u7684\u94f6\u884c\u5b58\u6b3e\u4e3a3,320\u4e07\u6fb3\u5143\uff0c\u8fc7\u53bb12\u4e2a\u6708\u7684\u5e73\u5747\u5b63\u5ea6\u652f\u51fa\u4e0d\u523050\u4e07\u6fb3\u5143\u3002<\/p>\n<h2>Presendin<\/h2>\n<p>Invex\u516c\u53f8\u5bf9\u76ee\u524d\u7528\u4e8e\u6cbb\u7597\u4e8c\u578b\u7cd6\u5c3f\u75c5\u7684\u836f\u7269\u827e\u585e\u90a3\u80bd\u8fdb\u884c\u4e86\u6539\u9020\u3002<\/p>\n<p>Invex\u5c06\u5176\u66f4\u540d\u4e3aPresendin\u3002Invex\u516c\u53f8\u5c06\u8fd9\u79cd\u836f\u7269\u7528\u4e8e\u6cbb\u7597\u9885\u5185\u538b\u5347\u9ad8\u5f15\u8d77\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u76ee\u524d\u4e13\u6ce8\u4e8e\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b\uff0c\u8ba4\u4e3a\u8fd9\u662f\u4e00\u4e2a\u5de8\u5927\u7684\u548c\u4e0d\u65ad\u589e\u957f\u7684\u5e02\u573a\u673a\u4f1a\uff0c\u76ee\u524d\u6ca1\u6709\u76d1\u7ba1\u673a\u6784\u6279\u51c6\u7684\u6cbb\u7597\u3002<\/p>\n<p>\u5f53\u8111\u810a\u6db2\u79ef\u7d2f\u5e76\u589e\u52a0\u8111\u5185\u538b\u529b\u65f6\uff0c\u5c31\u4f1a\u53d1\u751fIIH\u3002<\/p>\n<p>\u8fd9\u4f1a\u5bfc\u81f4\u60a3\u8005\u8870\u5f31\u7684\u75c7\u72b6\uff0c\u5305\u62ec\u65e5\u5e38\u5934\u75db\u548c\u89c6\u529b\u95ee\u9898\u3002<\/p>\n<p><a href=\"http:\/\/smallcaps-production.test\/invex-therapeutics-fda-meeting-phase-iii-trial-presendin-treatment-idiopathic-intracranial-hypertension\/?lang=cn\">Invex\u76ee\u524d\u6b63\u8ba1\u5212\u8fdb\u884cIII\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30Presendin\u5728IIH\u4e2d\u7684\u7597\u6548\u3002<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002 Invex\u4e13\u6ce8\u4e8e\u5c06Presendin\u5546\u4e1a\u5316\uff0c\u7528\u4e8e\u6cbb\u7597\u9885\u5185\u538b\u5347\u9ad8\u5f15\u8d77\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u3002 \u4eca\u5929\u7684\u65b0\u95fb\u662f\u5728\u65b0\u51a0\u80ba\u708e\u76f8\u5173\u6311\u6218\u548c\u5ef6\u8bef\u7684\u60c5\u51b5\u4e0b\u53d1\u5e03\u7684\u3002 Invex\u8bc4\u4f30\u4e86\u4e00\u4e9b\u4e13\u95e8\u7528\u4e8e\u4e34\u5e8a\u548c\u5546\u4e1a\u76ee\u7684\u7684\u80bd\u7684\u5408\u6210\u7684CMOs\u3002 \u4f5c\u4e3a\u8be5\u8fc7\u7a0b\u7684\u4e00\u90e8\u5206\uff0c\u8be5\u516c\u53f8\u6536\u5230\u4e86\u51e0\u4efd\u751f\u4ea7Presendin\u7684\u8be6\u7ec6\u63d0\u6848\uff0c\u7528\u4e8e\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\u548c\u5546\u4e1a\u4f9b\u5e94\u3002 \u8fd9\u4e9b\u5efa\u8bae\u7b26\u5408\u73b0\u884c\u4e25\u683c\u7684\u826f\u597d\u751f\u4ea7\u89c4\u8303\u76d1\u7ba1\u8981\u6c42\uff0c\u5305\u62ec\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u548c\u6b27\u6d32\u836f\u7269\u7ba1\u7406\u5c40\u6240\u89c4\u5b9a\u7684\u8981\u6c42\u3002 Invex\u968f\u540e\u5bf9\u5546\u4e1a\u4ea7\u91cf\u4e0b\u7684\u5355\u4f4d\u6210\u672c\u8fdb\u884c\u4e86\u989d\u5916\u5206\u6790\u3002\u8be5\u5206\u6790\u5305\u62ec\u6f5c\u5728\u7684\u5b9a\u4ef7\u7ed3\u6784\uff0c\u5e76\u8003\u8651\u5230\u5e02\u573a\u51c6\u5165\u52a8\u6001\u548c\u603b\u4f53\u60a3\u8005\u53ef\u63a5\u53d7\u6027\u3002 Invex\u8868\u793a:\u201c\u6709\u5173\u63d0\u8bae\u548c\u5408\u540c\u7684\u8ba8\u8bba\u5df2\u7ecf\u975e\u5e38\u6df1\u5165\uff0c\u6b63\u5728\u8fdb\u884c\u8fdb\u4e00\u6b65\u7684\u6cd5\u5f8b\u548c\u5546\u4e1a\u5ba1\u67e5\u3002\u201d \u201c\u4e00\u65e6\u5236\u9020\u9009\u62e9\u8fc7\u7a0b\u5b8c\u6210\uff0c\u5e76\u7b7e\u7f72\u6709\u7ea6\u675f\u529b\u7684\u5236\u9020\u534f\u8bae\uff0cInvex\u5c06\u66f4\u65b0\u5e02\u573a\u3002\u201d \u622a\u81f33\u6708\u5e95\uff0cInvex\u7684\u94f6\u884c\u5b58\u6b3e\u4e3a3,320\u4e07\u6fb3\u5143\uff0c\u8fc7\u53bb12\u4e2a\u6708\u7684\u5e73\u5747\u5b63\u5ea6\u652f\u51fa\u4e0d\u523050\u4e07\u6fb3\u5143\u3002 Presendin Invex\u516c\u53f8\u5bf9\u76ee\u524d\u7528\u4e8e\u6cbb\u7597\u4e8c\u578b\u7cd6\u5c3f\u75c5\u7684\u836f\u7269\u827e\u585e\u90a3\u80bd\u8fdb\u884c\u4e86\u6539\u9020\u3002 Invex\u5c06\u5176\u66f4\u540d\u4e3aPresendin\u3002Invex\u516c\u53f8\u5c06\u8fd9\u79cd\u836f\u7269\u7528\u4e8e\u6cbb\u7597\u9885\u5185\u538b\u5347\u9ad8\u5f15\u8d77\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u3002 \u8be5\u516c\u53f8\u76ee\u524d\u4e13\u6ce8\u4e8e\u7279\u53d1\u6027\u9885\u5185\u9ad8\u538b\uff0c\u8ba4\u4e3a\u8fd9\u662f\u4e00\u4e2a\u5de8\u5927\u7684\u548c\u4e0d\u65ad\u589e\u957f\u7684\u5e02\u573a\u673a\u4f1a\uff0c\u76ee\u524d\u6ca1\u6709\u76d1\u7ba1\u673a\u6784\u6279\u51c6\u7684\u6cbb\u7597\u3002 \u5f53\u8111\u810a\u6db2\u79ef\u7d2f\u5e76\u589e\u52a0\u8111\u5185\u538b\u529b\u65f6\uff0c\u5c31\u4f1a\u53d1\u751fIIH\u3002 \u8fd9\u4f1a\u5bfc\u81f4\u60a3\u8005\u8870\u5f31\u7684\u75c7\u72b6\uff0c\u5305\u62ec\u65e5\u5e38\u5934\u75db\u548c\u89c6\u529b\u95ee\u9898\u3002 Invex\u76ee\u524d\u6b63\u8ba1\u5212\u8fdb\u884cIII\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30Presendin\u5728IIH\u4e2d\u7684\u7597\u6548\u3002<\/p>\n","protected":false},"author":3,"featured_media":11633,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-07T00:23:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:49:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-Presendin-Exenatide-contract-manufacturing-organisation-CMO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf\" \/>\n<meta name=\"twitter:description\" content=\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/\",\"name\":\"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-05-07T00:23:49+00:00\",\"dateModified\":\"2023-08-29T17:49:24+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf","description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf","og_description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/","og_site_name":"smallcapsCN","article_published_time":"2021-05-07T00:23:49+00:00","article_modified_time":"2023-08-29T17:49:24+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Invex-Therapeutics-ASX-IXC-Presendin-Exenatide-contract-manufacturing-organisation-CMO.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf","twitter_description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/","name":"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-05-07T00:23:49+00:00","dateModified":"2023-08-29T17:49:24+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u5df2\u7ecf\u786e\u5b9a\u4e86\u51e0\u79cd\u9996\u9009\u7684\u5019\u9009\u914d\u65b9\uff0c\u5e76\u7f29\u5c0f\u4e86\u5bfb\u627e\u751f\u4ea7Presendin\u836f\u7269\u7684\u5408\u540c\u751f\u4ea7\u673a\u6784(CMO)\u7684\u8303\u56f4\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-narrows-search-cmo-manufacture-commercial-quantities-presendin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics\u7f29\u5c0f\u4e86\u5bf9\u9996\u9009\u9996\u5e2d\u8425\u9500\u5b98\u7684\u641c\u7d22\u8303\u56f4\uff0c\u4ee5\u751f\u4ea7Presendin\u7684\u5546\u4e1a\u6570\u91cf"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3070"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3070"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3070\/revisions"}],"predecessor-version":[{"id":11632,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3070\/revisions\/11632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/11633"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}